Category:

Sexual Health

Description / Intended Use:

melanocortin peptide product commonly discussed for skin pigmentation/tanning and libido-related effects. Melanotan II is not FDA-approved and has important safety concerns, including mole darkening, pigmentation changes, nausea, blood-pressure effects, and uncertain long-term dermatologic risk. It should not be promoted as a safe tanning solution, and patients should be directed to clinician guidance and skin monitoring.

Common clinical-style protocols

• Commonly scheduled once daily, often morning or evening, during recovery-focused periods.
• Amount per use should follow the prescriber label; intranasal recovery peptide dosing is not standardized.
• Frequency is usually daily or per prescriber-directed recovery plan.

Typical target exposure

Unapproved melanocortin exposure with unpredictable pigmentation and cardiovascular effects.

Common practical schedule

Avoid routine cosmetic use; if a clinician is involved, skin/mole monitoring and sun-safety counseling are essential.

Typical cycle length

No standard cycle; discontinue and seek medical review for mole changes, chest symptoms, severe nausea, or dark lesions.

Common side effects

Nausea, flushing, headache, appetite changes, libido changes, blood-pressure/heart-rate changes, darkening moles/freckles, new pigmentation, uncertain long-term melanoma-related risk.